Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About this market
The high demand for non-coils embolization devices is one of the critical reasons that will drive the transcatheter embolization and occlusion devices market. Non-coils embolization devices such as liquid embolic are preferred by surgeons as it support minimally invasive surgery. Flow diverting devices and embolization particles are some of the non-coils embolization devices that prevents catheter entrapment complication and imprecise deployment rates. The rising adoption of these devices in academic and research institutes, ASC, hospitals, and diagnostic centers will further drive the growth of the transcatheter embolization and occlusion devices market during the forecast period. analysts have predicted that the transcatheter embolization and occlusion devices market will register a CAGR of almost 8% by 2023.
Market Overview
High demand for non-coils embolization devices
One of the growth drivers of the global transcatheter embolization and occlusion devices market is the high demand for non-coils embolization devices. The rising popularity of non-coils embolization devices among end-users such as hospitals will drive the growth of the global transcatheter embolization and occlusion devices market during the forecast period.
Increasing number of product recalls
One of the challenges in the growth of the global transcatheter embolization and occlusion devices market is the increasing number of product recalls. This will slow down the launch of products in the market, which affects the sales and revenues of vendors.
For the detailed list of factors that will drive and challenge the growth of the transcatheter embolization and occlusion devices market during 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately fragmented and with the presence of several market players. Several vendors in the market are focusing on radioembolization or selective internal radiation therapy (SIRT) technology for treating patients with advanced cancer stages. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
The high demand for non-coils embolization devices is one of the critical reasons that will drive the transcatheter embolization and occlusion devices market. Non-coils embolization devices such as liquid embolic are preferred by surgeons as it support minimally invasive surgery. Flow diverting devices and embolization particles are some of the non-coils embolization devices that prevents catheter entrapment complication and imprecise deployment rates. The rising adoption of these devices in academic and research institutes, ASC, hospitals, and diagnostic centers will further drive the growth of the transcatheter embolization and occlusion devices market during the forecast period. analysts have predicted that the transcatheter embolization and occlusion devices market will register a CAGR of almost 8% by 2023.
Market Overview
High demand for non-coils embolization devices
One of the growth drivers of the global transcatheter embolization and occlusion devices market is the high demand for non-coils embolization devices. The rising popularity of non-coils embolization devices among end-users such as hospitals will drive the growth of the global transcatheter embolization and occlusion devices market during the forecast period.
Increasing number of product recalls
One of the challenges in the growth of the global transcatheter embolization and occlusion devices market is the increasing number of product recalls. This will slow down the launch of products in the market, which affects the sales and revenues of vendors.
For the detailed list of factors that will drive and challenge the growth of the transcatheter embolization and occlusion devices market during 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately fragmented and with the presence of several market players. Several vendors in the market are focusing on radioembolization or selective internal radiation therapy (SIRT) technology for treating patients with advanced cancer stages. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
